Vindoline Exhibits Anti-Diabetic Potential in Insulin-Resistant 3T3-L1 Adipocytes and L6 Skeletal Myoblasts

Type 2 diabetes mellitus (T2DM) emerged as a major health care concern in modern society, primarily due to lifestyle changes and dietary habits. Obesity-induced insulin resistance is considered as the major pathogenic factor in T2DM. In this study, we investigated the effect of vindoline, an indole...

Full description

Bibliographic Details
Main Authors: Beegum Noorjahan Shijina, Achuthan Radhika, Sainulabdeen Sherin, Prabath Gopalakrishnan Biju
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/15/13/2865
_version_ 1797591098602815488
author Beegum Noorjahan Shijina
Achuthan Radhika
Sainulabdeen Sherin
Prabath Gopalakrishnan Biju
author_facet Beegum Noorjahan Shijina
Achuthan Radhika
Sainulabdeen Sherin
Prabath Gopalakrishnan Biju
author_sort Beegum Noorjahan Shijina
collection DOAJ
description Type 2 diabetes mellitus (T2DM) emerged as a major health care concern in modern society, primarily due to lifestyle changes and dietary habits. Obesity-induced insulin resistance is considered as the major pathogenic factor in T2DM. In this study, we investigated the effect of vindoline, an indole alkaloid of <i>Catharanthus roseus</i> on insulin resistance (IR), oxidative stress and inflammatory responses in dexamethasone (IR inducer)-induced dysfunctional 3T3-L1 adipocytes and high-glucose-induced insulin-resistant L6-myoblast cells. Results showed that dexamethasone-induced dysfunctional 3T3-L1 adipocytes treated with different concentrations of vindoline significantly enhanced basal glucose consumption, accompanied by increased expression of GLUT-4, IRS-1 and adiponectin. Similarly, vindoline-treated insulin-resistant L6 myoblasts exhibited significantly enhanced glycogen content accompanied with upregulation of IRS-1 and GLUT-4. Thus, in vitro studies of vindoline in insulin resistant skeleton muscle and dysfunctional adipocytes confirmed that vindoline treatment significantly mitigated insulin resistance in myotubes and improved functional status of adipocytes. These results demonstrated that vindoline has the potential to be used as a therapeutic agent to ameliorate obesity-induced T2DM-associated insulin resistance profile in adipocytes and skeletal muscles.
first_indexed 2024-03-11T01:32:43Z
format Article
id doaj.art-e4a25957db8b4a2cbafd438985788cfe
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-11T01:32:43Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-e4a25957db8b4a2cbafd438985788cfe2023-11-18T17:13:35ZengMDPI AGNutrients2072-66432023-06-011513286510.3390/nu15132865Vindoline Exhibits Anti-Diabetic Potential in Insulin-Resistant 3T3-L1 Adipocytes and L6 Skeletal MyoblastsBeegum Noorjahan Shijina0Achuthan Radhika1Sainulabdeen Sherin2Prabath Gopalakrishnan Biju3Department of Biochemistry, University of Kerala, Kariavattom Campus, Thiruvananthapuram 695581, Kerala, IndiaDepartment of Biochemistry, Government College, Kariavattom, Thiruvananthapuram 695581, Kerala, IndiaDepartment of Biochemistry, PMS College of Dental Science and Research, Vattappara, Thiruvananthapuram 695028, Kerala, IndiaDepartment of Biochemistry, University of Kerala, Kariavattom Campus, Thiruvananthapuram 695581, Kerala, IndiaType 2 diabetes mellitus (T2DM) emerged as a major health care concern in modern society, primarily due to lifestyle changes and dietary habits. Obesity-induced insulin resistance is considered as the major pathogenic factor in T2DM. In this study, we investigated the effect of vindoline, an indole alkaloid of <i>Catharanthus roseus</i> on insulin resistance (IR), oxidative stress and inflammatory responses in dexamethasone (IR inducer)-induced dysfunctional 3T3-L1 adipocytes and high-glucose-induced insulin-resistant L6-myoblast cells. Results showed that dexamethasone-induced dysfunctional 3T3-L1 adipocytes treated with different concentrations of vindoline significantly enhanced basal glucose consumption, accompanied by increased expression of GLUT-4, IRS-1 and adiponectin. Similarly, vindoline-treated insulin-resistant L6 myoblasts exhibited significantly enhanced glycogen content accompanied with upregulation of IRS-1 and GLUT-4. Thus, in vitro studies of vindoline in insulin resistant skeleton muscle and dysfunctional adipocytes confirmed that vindoline treatment significantly mitigated insulin resistance in myotubes and improved functional status of adipocytes. These results demonstrated that vindoline has the potential to be used as a therapeutic agent to ameliorate obesity-induced T2DM-associated insulin resistance profile in adipocytes and skeletal muscles.https://www.mdpi.com/2072-6643/15/13/2865obesityT2DMinsulin resistancevindolineadipocyteskeletal muscle
spellingShingle Beegum Noorjahan Shijina
Achuthan Radhika
Sainulabdeen Sherin
Prabath Gopalakrishnan Biju
Vindoline Exhibits Anti-Diabetic Potential in Insulin-Resistant 3T3-L1 Adipocytes and L6 Skeletal Myoblasts
Nutrients
obesity
T2DM
insulin resistance
vindoline
adipocyte
skeletal muscle
title Vindoline Exhibits Anti-Diabetic Potential in Insulin-Resistant 3T3-L1 Adipocytes and L6 Skeletal Myoblasts
title_full Vindoline Exhibits Anti-Diabetic Potential in Insulin-Resistant 3T3-L1 Adipocytes and L6 Skeletal Myoblasts
title_fullStr Vindoline Exhibits Anti-Diabetic Potential in Insulin-Resistant 3T3-L1 Adipocytes and L6 Skeletal Myoblasts
title_full_unstemmed Vindoline Exhibits Anti-Diabetic Potential in Insulin-Resistant 3T3-L1 Adipocytes and L6 Skeletal Myoblasts
title_short Vindoline Exhibits Anti-Diabetic Potential in Insulin-Resistant 3T3-L1 Adipocytes and L6 Skeletal Myoblasts
title_sort vindoline exhibits anti diabetic potential in insulin resistant 3t3 l1 adipocytes and l6 skeletal myoblasts
topic obesity
T2DM
insulin resistance
vindoline
adipocyte
skeletal muscle
url https://www.mdpi.com/2072-6643/15/13/2865
work_keys_str_mv AT beegumnoorjahanshijina vindolineexhibitsantidiabeticpotentialininsulinresistant3t3l1adipocytesandl6skeletalmyoblasts
AT achuthanradhika vindolineexhibitsantidiabeticpotentialininsulinresistant3t3l1adipocytesandl6skeletalmyoblasts
AT sainulabdeensherin vindolineexhibitsantidiabeticpotentialininsulinresistant3t3l1adipocytesandl6skeletalmyoblasts
AT prabathgopalakrishnanbiju vindolineexhibitsantidiabeticpotentialininsulinresistant3t3l1adipocytesandl6skeletalmyoblasts